Ocumension Therapeutics
HKEX:1477.HK
5.46 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 246.367 | 158.957 | 56.146 | 13.096 | 0.19 | 0 |
| Cost of Revenue
| 102.002 | 56.041 | 19.211 | 1.724 | 0.01 | 0 |
| Gross Profit
| 144.365 | 102.916 | 36.935 | 11.372 | 0.18 | 0 |
| Gross Profit Ratio
| 0.586 | 0.647 | 0.658 | 0.868 | 0.947 | 0 |
| Reseach & Development Expenses
| 123.768 | 184.309 | 169.055 | 179.55 | 99.464 | 40.679 |
| General & Administrative Expenses
| 196.142 | 190.748 | 126.159 | 273.938 | 7.237 | 3.57 |
| Selling & Marketing Expenses
| 82.863 | 183.039 | 127.647 | 50.729 | 2.479 | 0 |
| SG&A
| 279.005 | 373.787 | 253.806 | 324.667 | 9.716 | 3.57 |
| Other Expenses
| -3.816 | -6.955 | -0.382 | -5.02 | 49.948 | -158.736 |
| Operating Expenses
| 545.705 | 551.141 | 422.479 | 499.197 | 159.128 | 49.448 |
| Operating Income
| -402.147 | -397.23 | -385.202 | -2,272.437 | -1,336.197 | -49.448 |
| Operating Income Ratio
| -1.632 | -2.499 | -6.861 | -173.521 | -7,032.616 | 0 |
| Total Other Income Expenses Net
| 22.667 | -4.999 | 125.21 | 7.571 | 10.716 | -159.957 |
| Income Before Tax
| -379.48 | -402.229 | -259.992 | -2,264.866 | -1,325.481 | -209.405 |
| Income Before Tax Ratio
| -1.54 | -2.53 | -4.631 | -172.943 | -6,976.216 | 0 |
| Income Tax Expense
| 0.307 | 0.414 | -125.21 | -7.571 | -23.886 | -159.952 |
| Net Income
| -379.787 | -402.643 | -134.782 | -2,257.295 | -1,301.595 | -207.608 |
| Net Income Ratio
| -1.542 | -2.533 | -2.401 | -172.365 | -6,850.5 | 0 |
| EPS
| -0.59 | -0.64 | -0.22 | -7.47 | -2.26 | -0.36 |
| EPS Diluted
| -0.59 | -0.64 | -0.22 | -7.47 | -2.26 | -0.36 |
| EBITDA
| -324.604 | -356.772 | -371.304 | -2,267.785 | -1,334.989 | -209.437 |
| EBITDA Ratio
| -1.318 | -2.244 | -6.613 | -173.166 | -7,026.258 | 0 |